Boosting mRNA Potential for Therapeutics, Gene-Editing & Vaccine Applications With Scalable Design, Guided Delivery, & Validated Clinical Safety for Patients
mRNA is no longer just a headline, it’s transforming medicine. From BioNTech’s acquisition of CureVac to the EMA’s and MHRA’s latest guidance on mRNA product development, and even the world’s first personalised CRISPR therapy for Baby KJ, the field has reached a new level of stability while opening doors to revolutionary therapeutic and gene editing applications.
Returning for its fifth year, the mRNA-Based Therapeutics Summit Europe gives you the insights and connections to turn these breakthroughs into action. The new Gene Editing Focus Day highlights how mRNA enables safer, transient editing strategies, while addressing regulatory and translational challenges. Hear directly from Moderna, AstraZeneca, CybernaX Bio, Avocet Bio, and others about clinical readiness and delivery innovations bringing therapies closer to patients.
With exclusive investor presentations and a high-profile panel featuring Innosuisse, NRW.Bank, and Lukasiewicz-PORT, you’ll gain candid perspectives on what makes an mRNA platform fundable in 2026, and actionable strategies to de-risk your programs and secure partnerships in today’s competitive landscape.
Built around case studies and never-before-seen preclinical and clinical data on mRNA delivery, stability, and next-generation modalities such as saRNA and circRNA, the summit unites 170+ senior leaders across R&D, CMC, business development, and regulation for three days of learning, networking, and collaboration to put you at the forefront of mRNA and gene editing innovation in 2026.
Data from later clinical development stage/clinical data was presented. This was interesting.
Senior Vice President, BioNTech
This was an excellent conference, by far one of the best mRNA conferences I have attended. Excellent meeting to meet the leaders in the field. The scientific program, the exchange and the networking were excellent.
Chief Executive Officer, DivinCell
The diversity of topics and attendees was good (suppliers, drug developers, CDMOs, regulatory specialists)
Director, Merck KGaA
Explore the Full Event Guide
- Reshape gene editing strategies with mRNA and explore its role in safer, transient editing, novel delivery approaches, with translational case studies giving you actionable insights to advance next-generation therapies
- Uncover the latest clinical and preclinical insights and find solutions to advance technology innovation and manufacturing, including mRNA architecture and LNP design
- Connect with leading biopharma and position your team at the forefront of emerging therapeutic opportunities, with firsthand insights into investment trends, partnerships, and expansion into mRNA drug pipelines
Official Partners
Attending Companies Include
Explore the Agenda
Dive into cutting-edge mRNA-based therapeutics with insights from leading biopharma, biotech, and academic experts.
Partner With Us
Showcase your technologies and services to senior decision-makers driving next-generation mRNA innovation.
Join Biopharma Experts
Be part of the only European meeting uniting pre-clinical, clinical, manufacturing, regulatory, and investor experts in the mRNA space.